Japan’s Generic Market Projected To Pass $7 Billion in 2014
This article was originally published in PharmAsia News
Japan’s market for generic drugs is expected to pass $7 billion in 2014, an increase of one- third since 2010, far outpacing the overall pharmaceutical market expected to grow by 5.8%.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.